EVIDENCE-BASED THERAPEUTIC ACTIVITY OF POMEGRANATE AND ITS ACTIVE CONSTITUENT ELLAGIC ACID

被引:0
|
作者
Mansoury, Manal M. S. [1 ]
机构
[1] King Abdulaziz Univ, Fac Home Econ, Dept Food & Nutr, Jeddah, Saudi Arabia
来源
PHARMACOPHORE | 2019年 / 10卷 / 01期
关键词
Pomegranate juice; ellagic acid; therapeutic activity; DOUBLE-BLIND; OXIDATIVE STRESS; ANTIOXIDANT STATUS; LIPID-PEROXIDATION; JUICE CONSUMPTION; DIABETIC-PATIENTS; EXTRACT; POLYPHENOLS; EFFICACY; IMPROVEMENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Presently pomegranate is used in traditional medicine for its pharmacological properties. Consumption of fresh vegetables and fruits can improve the human health mainly because of their high contents of beneficial phytochemicals and other micronutrients. Pomegranate has multiple pharmacological activities including anti-inflammatory, antioxidant, and anticancer actions. Ellagic acid is a major compound of pomegranate which is naturally existing in many kinds. It has also been found in raspberries, blackberries, cranberries, strawberries, pecans, walnuts, green tea, pomegranates, and blueberries. Recently, numerous studies have proven the effectiveness of ellagic acid and pomegranate juice in the treatment of prostate cancer, diabetes, melasma, ultraviolet radiation-induced skin damage, endotoxemia, rheumatoid arthritis and osteoarthritis, cardiovascular diseases, blood pressure, hyperlipidemia, erectile dysfunction, dental disorders, diabetes, and idiopathic central precocious puberty. The therapeutic effect of ellagic acid and pomegranate juice could be due to the clinically evidenced antioxidant activities. In conclusion, ellagic acid may be used as a therapy or adjuvant therapy for the treatment of many illnesses. Copyright (c) 2013-All Rights Reserved-Pharmacophore.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 50 条
  • [31] Evidence-based Therapeutic Drug Monitoring for Nevirapine
    Muret, Patrice
    Piedoux, Sarah
    Solas, Caroline
    Quaranta, Sylvie
    THERAPIE, 2011, 66 (03): : 187 - 195
  • [32] Therapeutic herbs confirmed by evidence-based medicine
    Thornfeldt, Carl R.
    CLINICS IN DERMATOLOGY, 2018, 36 (03) : 289 - 298
  • [33] Evidence-based Therapeutic Drug Monitoring for Ribavirine
    Solas, Caroline
    Pare, Maxime
    Quaranta, Sylvie
    Stanke-Labesque, Francoise
    THERAPIE, 2011, 66 (03): : 221 - 230
  • [34] Evidence-based Therapeutic Drug Monitoring of Atazanavir
    Solas, Caroline
    Muret, Patrice
    THERAPIE, 2011, 66 (03): : 213 - 219
  • [35] Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation
    Yoshimura, M
    Watanabe, Y
    Kasai, K
    Yamakoshi, J
    Koga, T
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2005, 69 (12) : 2368 - 2373
  • [36] Therapeutic and preventive properties of honey and its bioactive compounds in cancer: an evidence-based review
    Afrin, Sadia
    Haneefa, Shoja M.
    Fernandez-Cabezudo, Maria J.
    Giampieri, Francesca
    al-Ramadi, Basel K.
    Battino, Maurizio
    NUTRITION RESEARCH REVIEWS, 2020, 33 (01) : 50 - 76
  • [37] Antifungal Activity of Glycyrrhiza glabra Extracts and its Active Constituent Glabridin
    Fatima, Atiya
    Gupta, Vivek K.
    Luqman, Suaib
    Negi, Arvind S.
    Kumar, J. K.
    Shanker, Karuna
    Saikia, Dharmendra
    Srivastava, Suchita
    Darokar, M. P.
    Khanuja, Suman P. S.
    PHYTOTHERAPY RESEARCH, 2009, 23 (08) : 1190 - 1193
  • [38] Evidence-based uncertainty sampling for active learning
    Sharma, Manali
    Bilgic, Mustafa
    DATA MINING AND KNOWLEDGE DISCOVERY, 2017, 31 (01) : 164 - 202
  • [39] Are postoperative activity restrictions evidence-based?
    Guttormson, Robert
    Tschirhart, James
    Boysen, Dennis
    Martinson, Kurt
    AMERICAN JOURNAL OF SURGERY, 2008, 195 (03): : 401 - 403
  • [40] Evidence-based uncertainty sampling for active learning
    Manali Sharma
    Mustafa Bilgic
    Data Mining and Knowledge Discovery, 2017, 31 : 164 - 202